Journal Guide

Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine.Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.Read More: http://informahealthcare.com/page/phb/Description.

Pharmaceutical Development and Technology publishes research in the design, development, manufacture, and evaluation of traditional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems.Through basic and applied research articles, review papers, short reports, and book reviews, Pharmaceutical Development and Technology covers topics such as: *Preformulation evaluation of pharmaceutical materials *Physical pharmacy and formulation *Research process engineering and scale-up of drug delivery systems *Drug delivery systems evaluation and quality improvement *Global standardization of pharmaceutical information.

Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others. Pharmaceutical Research publishes twelve issues a year.

Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of pharmaceutical products and molecular medicine. Related news and announcements can also published. Our aim is to publish as much as possible the theoretical and experimental details. Therefore, there is no restriction on the length of a paper. There are in addition three unique features: Manuscripts regarding research proposals and research ideas will be particularly welcomed. Electronic files regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, will be deposited as supplementary material. Samples of the pharmaceutical products can be deposited into the samples collection of MDPI.

Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications, and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds

Pharmacognosy Magazine (Phcog Mag.) is Published Quarterly, Pharmacognosy Magazine (Phcog Mag.) serves the need of different scientists and others involved in medicinal plant research and development. Each issue covers different topics in natural product drug discovery, and also publishes manuscripts that describe investigations, clinical reports, methods, techniques and applications of all forms of medicinal plant research and that are of broad readership interest to users in industry, academia, and government. Phcog Mag. is a must-read magazine for medicinal Plant researchers —and it's an Open Access Publication.